Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer-Reference-Cited by-同舟云学术

Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer

Published:2018-10-09 Issue:1 Volume:35 Page:370-374
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Paris Ida¹,Cianci Stefano¹^ORCID,Vizzielli Giuseppe¹,Fagotti Anna²,Ferrandina Gabriella²,Gueli Alletti Salvatore¹,Costantini Barbara¹,Cosentino Francesco¹,Capoluongo Ettore³,Pasqualoni Mariangela¹,Scambia Giovanni²

Affiliation:

1. Department of Women’s and Children’s Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;

2. Department of Women’s and Children’s Health, Fondazione Policlinico Universitario A. Gemelli IRCCS and Universita’ Cattolica, Rome, Italy;

3. Department of Clinical Chemistry, Fondazione Policlinico Universitario A. Gemelli IRCCS and Universita’ Cattolica, Rome, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2018.1503346

Reference29 articles.

1. Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–vi32. Available from: http://www.esmo.org/Guidelineshttp://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

2. Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer

3. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

4. Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral–Peritoneal Debulking (VPD) in patients with stage IIIC–IV ovarian cancer

5. Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery;Surgical Oncology Insight;2024-09

2. Exploring the Relationship between Ovarian Cancer and Genital Microbiota: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-03-27

3. Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods;International Journal of Gynecologic Cancer;2023-09-05

4. Clinical Efficacy and Safety of Tumor Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer;Evidence-Based Complementary and Alternative Medicine;2023-04-12

5. Effets secondaires des CHIP et implications sur les traitements post-chirurgicaux. L’avis d’une oncologue médicale;Bulletin du Cancer;2023-02